Shrink Nanotechnologies' Biotech R&D Group Files Key Patent on StemDisc(TM ... MarketWatch (press release)
, An innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that patent applications for its stem cell research and drug discovery tool StemDisc(TM) have been filed.StemDisc is Shrink's latest bioscience application of its proprietary, patent-pending, advanced plastic material called NanoShrink(TM). StemDisc offers a low cost, flexible and cost effective solution for biotech researchers to conduct experiments for (i) drug discovery, (ii) regenerative medicine (ii) and cancer research, among others. Following a lift on the ban to federally fund stem cell research, President Obama said in his speech on March 9, 2009, "Embryonic stem cell research could help us understand, and possibly cure, some of our most devastating diseases and conditions."


